28 September 2021
Excessive regulation of the Russian pharmaceutical market and the lack of drug insurance system is leading to a shortage of some vital and effective drugs in the local market, according to recent statements by representatives of producers and analysts.
26 July 2021
NovaMedica, a Russian pharmaceutical company and portfolio project of the national nanotech company Rusnano, has developed what might emerge into a market-winning new drug for colorectal therapy.
31 May 2021
Concern Bayer will expand its portfolio of drugs for the treatment of hemorrhoids with the development of the Russian “NovaMedica” based on nifedipine and lidocaine. The German company already holds about 40% of the market for such funds. Pharmaceutical market experts call the deal one of the rare ones: foreign companies do not often acquire rights to Russian medicines.
29 July 2019
Major Russian pharmaceutical company NovaMedica and the US-based Unipharm have launched a joint project to localize in Russia the production of Melaxen®, a hormone secreted by the pineal gland in a 24-hour circadian rhythm, regulating the normal sleep/wake cycle. Production capacity expected to reach hundreds of thousands of packages per year. It will be enough to meet the requirements of patients living in the territory of the EAEU.
23 July 2019
The Russian pharmaceutical market is considered to be one of the most dynamic ones. In recent years, the annual growth is about 10%. The state policy that stimulates the production localization is effectively implemented. A new investment instrument has been launched in Russia – a special investment contract (SPIC). On March 7, 2018, NovaMediña, a portfolio company of RUSNANO, concluded the largest in the pharmaceutical industry a special investment contract (SPIC) with the Russian Federation represented by the Ministry of Industry and Trade of Russia and the Kaluga Region to establish the production of sterile injectable dosage forms.
19 June 2019
Russian drug companies NovaMedica and Pharmsynthez have launched a joint project to make a number of effective drugs available to Russian patients within 1.5-2 years. Integrated local production of these drugs will be set up in Russia, RUSNANO informed.
18 April 2019
Si quiere atraer a un socio internacional (proveedor) para localizar en su empresa sus productos, debe seguir con exactitudm las normas internacionales. Conocer y ser capaz de realizar transferencia correctamente. Al parecer, no hay de que discutir. Pero aun, prevalecen los antiguos enfoques en la organization de transferencia de tecnologias farmaceuticas: "Escribannos los componentes, y nosotros lo dominaremos todo aqui por nuestra cuenta".
11 February 2019
Der Mannheimer Industriedienstleister Bilfinger hat vom russischen Pharmaunternehmen Novamedica den Auftrag zur Lieferung einer Arzneimittel-Produktionsanlage erhalten. Das Projekt soll von Bilfinger Industrietechnik Salzburg abgewickelt werden und umfasst die Konstruktion und Errichtung von drei Ansatzsystemen zur Herstellung steriler Arzneiformen. Es ist der erste Auftrag für das Bilfinger-Tochterunternehmen Russland.
22 January 2019
For seven years past from its existence Kaluga Pharmaceutical Cluster has been dynamically developing significantly exceeding the growth rates in other economic sectors of the region. And the question is not only about opening of manufacturing facilities but also about further localization and extension of manufacturing capacity of already existing plants of both Russian and foreign manufacturers. 2018 was no exception. In March of 2018, NovaMedica LLC concluded a special investment contract (SPIC) with the Russian Ministry of Industry and Trade and Kaluga Region.
11 December 2018
NIBIB-funded researchers recently validated a rapid STD test that delivered accurate results in about 30 minutes for chlamydia, allowing patients to receive treatment immediately, thereby stemming the further spread of disease. Other analyses showed most women preferred the easy self-collection method the test offers.
14 October 2021
14 October 2021
13 October 2021
13 October 2021